The Swiss government is proposing to ensure that treatment costs for homeopathy and anthroposophic medicine will continue to be reimbursed by compulsory health insurance on a par with other medical disciplines.
RSS feed
Board meeting, workshop on the Delegated Act on Safety Features for Medicinal Products for Human Use
Homeopathy Research Institute are organising the next International Homeopathy Research Conference in Malta on 9-11 June, 2017.
A new survey finds that 2.1% of US adults have used homeopathy within the past 12 months.
ECHAMP’s annual report for 2015 is now available to download from our website. Gesine Klein and Christiaan Mol, ECHAMP’s President and General Secretary, appeal to friends, supporters, stakeholders, politicians and policy makers for their support for ECHAMP’s work towards a healthy regulatory governance for this industry sector that takes its specific characteristics into due account.
New research shows that 80% of the British population are aware of homeopathy, and 79% open to it. A lack of information and understanding are the highest barriers to use.
Positive new developments on homeopathy and anthroposophic medicine often get little media coverage, while attacks on the sector are commonplace, although not always founded on fact. In a brief round-up of relevant news items, we provide useful links and background to some of the recent news stories of relevance to the debate about our sector – both positive and negative.
Homeopathic medicinal products are exempt from the inclusion of safety features now required under new EU legislation on the packaging of many other medicinal products, saving the sector up to €1.4m in investment.
A recent ruling by the European Court of Justice confirms that there is no obligation to pay tax on ethanol used for cleaning purposes during the production of medicinal products. This ruling has additional implications for the manufacturers of homeopathic medicinal products.
ECHAMP provides a round-up of Parliamentary Written Questions in 2015 on this and related topics, and summarises the Commission’s answers.
The Homeopathic Medicinal Products Working Group (HMPWG) has published a report on its meeting in November.
Changes at the Directorate General for Health at the European Commission mean some new faces in units relevant to homeopathic and anthroposophic medicinal products.
A US jury has found that a manufacturer of homeopathic products was not in breach of legislation on false advertising.
New ECHAMP website: now accessible on mobile and on tablet.
Pharmapolitical developments, publication ‘Homeopathic and Anthroposophic Medicinal Products in the EU – Profile of an Industry 2015’
Raw materials, suppliers, mother tinctures and potentisation
ECHAMP is compiling feedback on two new documents concerning the lists of justified homeopathic stocks, released for consultation by the HMPWG.
Meeting with the Commissioner, European Parliament CAM Interest Group, upgrade of Advocacy Pack for Members
The market for homeopathic and anthroposophic medicinal products in the EU is growing by 6.5% a year. It is now valued at €1.24 billion per year which represents 7% of the total EU market for non-prescription products. ECHAMP’s new report, ‘Homeopathic and Anthroposophic Medicinal Products in the EU – Profile of an industry 2015,’ provides a comprehensive review of the sector and, for the first time, profiling in detail this unique industry.
Terms and conditions for use of the site - copyright and website disclaimer
The EU legal framework for homeopathic medicinal products
New publication ‘Homeopathic and Anthroposophic Medicinal Products in the EU – Profile of an Industry 2015’, consultation on the registration process in Norway
More EU investment needed for research in homeopathy and anthroposophic medicine.
New ECHAMP President will continue the fight to put homeopathic and anthroposophic medicinal products on the EU agenda.
The third edition of Facts & Figures - 2011
There is sufficient evidence for the clinical efficacy of homeopathy and for its safety and economy compared to conventional treatment.
to Mrs Nelly Kroes & Mr John Dalli on the Active and Healthy Ageing Innovation Partnership
to Green Paper - From Challenges to Opportunities: Towards a Common Strategic Framework for EU Research and Innovation funding
to Public Consultation Paper Review of the Variations Regulation - Review of Commission Regulation (EC) No 1234/2008
to stakeholder consultation on Smart Regulation in the EU - Follow up to the 2012 Communication on Smart Regulation